USA flag logo/image

An Official Website of the United States Government

Company Information:

Name: Ribi Immunochem Research, Inc.
Address: 553 OLD CORVALLIS RD
Hamilton, MO 59840
Located in HUBZone: No
Woman-Owned: No
Minority-Owned: No
URL: N/A
Phone: (406) 363-6214

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $249,000.00 4
SBIR Phase II $749,918.00 1

Award List:

THE OBJECTIVE OF THIS PROJECT IS TO DEVELOP A VACCINE DELIVERY SYSTEM WHICH WILL STIMULATE, RAPIDLY, A STATE OF NON-SPECIFIC PROTECTION WHILE IT ENHANCES THE SPECIFIC IMMUNE RESPONSE TO THE VACCINE AND SHORTENS THE INDUCTION PERIOD FOR DEVELOPMENT OF

Award Year / Program / Phase: 1986 / SBIR / Phase I
Agency / Branch: DOD / ARMY
Principal Investigator: J terry ulrich
Award Amount: $50,000.00
Abstract:
The objective of this project is to develop a vaccine delivery system which will stimulate, rapidly, a state of non-specific protection while it enhances the specific immune response to the vaccine and shortens the induction period for development of specific immunity. this will be accomplished by… More

BACTERIAL ENDOTOXINS AND OTHER MATERIALS OF MICROBIAL ORIGINHAVE BEEN PREPARED IN NONTOXIC AND NONALLERGENIC FORMS THAT RETAIN THE CAPACITY TO MODIFY, IN A BENEFICIAL FASHION, CERTAIN BIOLOGICAL RESPONSES.

Award Year / Program / Phase: 1986 / SBIR / Phase I
Agency: HHS
Principal Investigator: John cantrell , PRINCIPAL INVESTIGATOR
Award Amount: $50,000.00
Abstract:
Bacterial endotoxins and other materials of microbial originhave been prepared in nontoxic and nonallergenic forms that retain the capacity to modify, in a beneficial fashion, certain biological responses. the ultimate objective of these investigations is to provide, in a cost-effective manner,… More

LIPOSOME-IMMUNOSTIMULANT ADJUVANT SYSTEM

Award Year / Program / Phase: 1987 / SBIR / Phase I
Agency: HHS
Principal Investigator: Kent r myers
Award Amount: $49,000.00
Abstract:
This project is directed toward development and testing of a liposomal adjuvant system that will engender a strong and sustained immune response to antigens of low immunogenicity. this adjuvant system will consist of liposomes that contain one or more nontoxic immunopotentiators of microbial or… More

SYNTHETIC MONOSACCHARIDE ADJUVANTS FOR HUMAN VACCINES

Award Year / Program / Phase: 1997 / SBIR / Phase I
Agency: HHS
Principal Investigator: Johnson, david a
Award Amount: $100,000.00

N/A

Award Year / Program / Phase: 1999 / SBIR / Phase II
Agency: HHS
Principal Investigator: Johnson david a
Award Amount: $749,918.00